• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Medical Device Market
    Medical Device News
    Medical Device Stocks
    • Medical Device Market
    • Medical Device News
    • Medical Device Stocks
    medical device investing

    Neovasc Announces Date of Share Consolidation

    Jocelyn Aspa
    Jun. 28, 2019 08:58AM PST
    Medical Device Investing

    Neovasc (TSX:NVCN, NASDAQ:NVCN) has announced the date of its share consolidation of its issued and outstanding common shares. As quoted in the press release: The Consolidation will reduce the number of Common Shares issued and outstanding from approximately 74,811,888 Common Shares to approximately 7,481,157 Common Shares. The Common Shares are expected to commence trading on …

    Neovasc (TSX:NVCN, NASDAQ:NVCN) has announced the date of its share consolidation of its issued and outstanding common shares.

    As quoted in the press release:

    The Consolidation will reduce the number of Common Shares issued and outstanding from approximately 74,811,888 Common Shares to approximately 7,481,157 Common Shares. The Common Shares are expected to commence trading on the Toronto Stock Exchange (the “TSX“) and on the Nasdaq Capital Market on a post-Consolidation basis on or about the opening of trading on July 2, 2019.

    The Company’s transfer agent, Computershare Investor Services Inc., is anticipated to send a letter of transmittal on July 2, 2019 to the registered holders of Common Shares. The letter of transmittal will contain instructions on how to surrender Common Share certificate(s) representing pre-Consolidation Common Shares to the transfer agent. Shareholders may also obtain a copy of the letter of transmittal by accessing the Company’s SEDAR profile at www.sedar.com or the Company’s EDGAR profile at www.sec.gov. Until surrendered, each certificate representing pre-Consolidation Common Shares will be deemed for all purposes to represent the number of Common Shares to which the holder thereof is entitled as a result of the Consolidation. If shareholders hold their Common Shares through an intermediary and they have questions in this regard, they are encouraged to contact their intermediaries.

    Click here to read the full press release.

    tsx:nvcnshare consolidationmedical device investingnasdaq:nvcn
    The Conversation (0)

    Go Deeper

    AI Powered
    QNB Metals (CSE:TIM.X)

    QNB Signs Definitive Agreement, Finalizes Terms for Biofuel and Hydrogen Technology

    Aether Global Announces Effective Date of Share Consolidation

    Aether Global Announces Effective Date of Share Consolidation

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Medical Device Investing Stocks

    Cardiex Limited

    CDX:AU
    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×